BMC Research Notes · 2012 · 18 citations · 9 references
Life SciencesImmunologyPathologyAutoimmunityDermatopathologyImmunopathologyAutoantibodiesAutoimmune DiseasesAutoimmune Skin DiseasesAutoimmune VasculitisOrgan-specific Autoimmune DiseasesSystemic Autoimmune DiseaseAutoimmune Skin ManifestationsLocalized SclerodermaSkin Manifestations Of VasculitisThrombopoietin Receptor AgonistsThyroid Autoantibodies
BACKGROUND: The localized scleroderma (LS) known as morphea, presents a variety of clinical manifestations that can include systemic involvement. Current classification schemes divide morphea into categories based solely on cutaneous morphology, without reference to systemic disease or autoimmune phenomena. This classification is likely incomplete. Autoimmune phenomena such as vitiligo and Hashimoto thyroiditis associated with LS have been reported in some cases suggesting an autoimmune basis. To our knowledge this is the first case of a morphea forming part of a multiple autoimmune syndrome (MAS) and presenting simultaneously with autoimmune thrombocytopenic purpura and central nervous system vasculitis. CASE PRESENTATION: We report an uncommon case of a white 53 year old female patient with LS as part of a multiple autoimmune syndrome associated with pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis presenting a favorable response with thrombopoietin receptor agonists, pulses of methylprednisolone and cyclophosphamide. CONCLUSION: Is likely that LS have an autoimmune origin and in this case becomes part of MAS, which consist on the presence of three or more well-defined autoimmune diseases in a single patient.
9
Distinct Autoimmune Syndromes in Morphea
Justin J. Leitenberger, Rachael Cayce, Robert W. Haley et al. · Archives of Dermatology · 2009 · 258 citations · Full text